Emergency medical services transport a 28-year-old female patient to the resuscitation bay due to an uninterrupted generalized tonic-clonic seizure. According to paramedic transport records, the active seizing started 15 minutes prior to arrival and has not abated. The patient remains unresponsive. Point-of-care blood glucose testing is 95 mg/dL. Bilateral large-bore intravenous catheters are secured.
Arrange the following pharmacologic interventions in the standard, guideline-concordant sequence for escalating the management of this patient's condition.
- 1Administer intravenous lorazepam
- 2Administer intravenous levetiracetam
- 3Initiate continuous intravenous propofol infusion
Cevap
The correct sequence of pharmacologic escalation is to first administer intravenous lorazepam, followed by intravenous levetiracetam, and finally initiate a continuous intravenous propofol infusion if the seizures remain refractory.
The established protocol for status epilepticus management follows a strictly defined timeline. The initial therapy phase (0-20 minutes) requires an emergent benzodiazepine such as intravenous lorazepam to rapidly halt the seizure. The second therapy phase (20-40 minutes) involves administering a long-acting antiepileptic drug, such as intravenous levetiracetam, fosphenytoin, or valproic acid, to prevent recurrence. If seizures persist into the third therapy phase (>40 minutes), the condition is termed refractory status epilepticus, and treatment must escalate to continuous infusions of general anesthetics like propofol, midazolam, or pentobarbital alongside mechanical ventilation.
Adım Adım Çözüm
Anahtar Kavram
The standard pharmacologic escalation for generalized convulsive status epilepticus progresses sequentially from an emergent intravenous benzodiazepine, to a long-acting non-benzodiazepine antiepileptic drug, and finally to a continuous infusion of a general anesthetic if the condition becomes refractory.
Tahmini Süre:1m 0s